News & Updates
Filter by Specialty:
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
06 Jul 2022
Acute kidney injury tied to worse outcomes in kidney transplant recipients with UTI
The development of acute kidney injury (AKI) seems to worsen the risk of graft loss in kidney transplant recipients (KTRs) with urinary tract infection (UTI), a recent study has found.
Acute kidney injury tied to worse outcomes in kidney transplant recipients with UTI
06 Jul 2022
Chlorhexidine a safe, reasonable option for vaginal antisepsis
Vaginal antisepsis with chlorhexidine proves noninferior to that with iodine in terms of the incidence of gynaecologic surgery-associated urinary tract infection and vaginal irritation, as reported in a study.
Chlorhexidine a safe, reasonable option for vaginal antisepsis
06 Jul 2022
Healthy lifestyle helps prevent, delay benign prostatic hyperplasia
Keeping healthy lifestyle habits, such as avoiding smoking, engaging in exercise, and limiting alcohol intake, helps prevent or delay the development of benign prostatic hyperplasia (BPH), a new Japan study has found.
Healthy lifestyle helps prevent, delay benign prostatic hyperplasia
05 Jul 2022
PARG inhibition slows HCC progression, boosts efficacy of immune checkpoint therapy
In hepatocellular carcinoma (HCC), poly(ADP-ribose) glycohydrolase (PARG) may serve as an oncogene by modulating PARG/DDB1/c-Myc signaling and be used as a biomarker to identify HCC patients who may derive benefit from anti-PD-1 treatment, suggests a study.
